DOP2010000374A - Derivados heterociclicos de la urea y sus metodos de empleo - Google Patents

Derivados heterociclicos de la urea y sus metodos de empleo

Info

Publication number
DOP2010000374A
DOP2010000374A DO2010000374A DO2010000374A DOP2010000374A DO P2010000374 A DOP2010000374 A DO P2010000374A DO 2010000374 A DO2010000374 A DO 2010000374A DO 2010000374 A DO2010000374 A DO 2010000374A DO P2010000374 A DOP2010000374 A DO P2010000374A
Authority
DO
Dominican Republic
Prior art keywords
heterociclical
urea
derivatives
employment methods
employment
Prior art date
Application number
DO2010000374A
Other languages
English (en)
Inventor
Brian Sherer
Fei Zhou
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40848376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DOP2010000374(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of DOP2010000374A publication Critical patent/DOP2010000374A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Se describen compuestos químicos, compuestos de fórmula (I) y sus sales farmacéuticamente aceptables. Se describen también procesos para su preparación, composiciones farmacéuticas que los contienen, su uso como medicamentos y su uso en el tratamiento de infecciones bacterianas.
DO2010000374A 2008-06-04 2010-12-03 Derivados heterociclicos de la urea y sus metodos de empleo DOP2010000374A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5872808P 2008-06-04 2008-06-04
US15409309P 2009-02-20 2009-02-20

Publications (1)

Publication Number Publication Date
DOP2010000374A true DOP2010000374A (es) 2011-01-15

Family

ID=40848376

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2010000374A DOP2010000374A (es) 2008-06-04 2010-12-03 Derivados heterociclicos de la urea y sus metodos de empleo

Country Status (22)

Country Link
US (1) US20090325902A1 (es)
EP (1) EP2313402A1 (es)
JP (1) JP2011522030A (es)
KR (1) KR20110019737A (es)
CN (1) CN102105468A (es)
AR (1) AR072046A1 (es)
AU (1) AU2009254937A1 (es)
BR (1) BRPI0913583A2 (es)
CA (1) CA2725572A1 (es)
CL (1) CL2009001345A1 (es)
CO (1) CO6351722A2 (es)
CR (1) CR11824A (es)
DO (1) DOP2010000374A (es)
EA (1) EA201001859A1 (es)
EC (1) ECSP10010659A (es)
IL (1) IL209500A0 (es)
MX (1) MX2010013251A (es)
PE (1) PE20091959A1 (es)
TW (1) TW201002728A (es)
UY (1) UY31865A (es)
WO (1) WO2009147440A1 (es)
ZA (1) ZA201008609B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012010666A (es) 2010-03-31 2012-10-05 Actelion Pharmaceuticals Ltd Derivados de isoquinolin-3-ilurea antibacterianos.
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
US9120752B2 (en) 2010-07-16 2015-09-01 Purdue Pharma, L.P. Pyridine compounds as sodium channel blockers
AR088729A1 (es) 2011-03-29 2014-07-02 Actelion Pharmaceuticals Ltd Derivados de 3-ureidoisoquinolin-8-ilo y una composicion farmaceutica
AU2013203824A1 (en) 2012-03-16 2013-10-03 Purdue Pharma L.P. Substituted pyridines and pryimidines as sodium channel blockers
EP2935257B1 (en) 2012-12-20 2018-02-07 Purdue Pharma LP Cyclic sulfonamides as sodium channel blockers
CN106866571B (zh) * 2017-01-20 2018-06-29 中国药科大学 杂环脲类化合物及其药物组合物和应用
WO2018174288A1 (ja) 2017-03-24 2018-09-27 大正製薬株式会社 ２（１ｈ）－キノリノン誘導体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135953A (en) * 1984-12-28 1992-08-04 Ciba-Geigy Use of acyl urea compounds for controlling endoparasites and ectoparasites of warm-blooded animals
MXPA03005298A (es) * 2000-12-15 2003-10-06 Vertex Pharma Inhibidores de girasa y usos de los mismos.
WO2006092599A2 (en) * 2005-03-04 2006-09-08 Astrazeneca Ab Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
CN101627038A (zh) * 2006-12-04 2010-01-13 阿斯利康(瑞典)有限公司 抗菌多环脲化合物

Also Published As

Publication number Publication date
CL2009001345A1 (es) 2010-06-11
US20090325902A1 (en) 2009-12-31
AR072046A1 (es) 2010-08-04
CR11824A (es) 2011-01-12
MX2010013251A (es) 2010-12-21
BRPI0913583A2 (pt) 2015-10-27
IL209500A0 (en) 2011-01-31
CN102105468A (zh) 2011-06-22
PE20091959A1 (es) 2010-02-13
AU2009254937A1 (en) 2009-12-10
TW201002728A (en) 2010-01-16
EP2313402A1 (en) 2011-04-27
KR20110019737A (ko) 2011-02-28
CO6351722A2 (es) 2011-12-20
EA201001859A1 (ru) 2011-08-30
ECSP10010659A (es) 2011-01-31
CA2725572A1 (en) 2009-12-10
JP2011522030A (ja) 2011-07-28
UY31865A (es) 2010-01-29
WO2009147440A1 (en) 2009-12-10
ZA201008609B (en) 2011-08-31

Similar Documents

Publication Publication Date Title
CR11641A (es) Derivados heterociclicos de urea y metodos de uso de los mismos-211
UY32158A (es) Derivados heterociclicos y metodos de uso de los mismos
UY30759A1 (es) Compuestos quimicos
DOP2010000374A (es) Derivados heterociclicos de la urea y sus metodos de empleo
UY32315A (es) Compuestos de piperidina y usos de los mismo-596
UY30544A1 (es) Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones
UY31141A1 (es) Compuestos de piperidina y sus usos
UY31864A (es) Derivados de urea hetericíclica y métodos de uso de los mismos-332
UY31860A (es) Piridinas de tiazolo como inhibidoras de la adn girasa
UY32674A (es) Derivados heterociclicos de la urea y sus metodos de empleo
UY28510A1 (es) Compuestos quimicos
UY31481A1 (es) Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones
UY31069A1 (es) Nuevos derivados de imidazoquinola, composiciones conteniendolos, proceso de preparacion y aplicaciones
UY32203A (es) Amino pirimidinas y su uso en terapia
UY32856A (es) Derivados heterocíclicos de urea y métodos de uso de los mismos
UY29384A1 (es) Derivados del ácido2-3s,4r)-4-(((3,4-dicloro-5-metil-1h-pirrol-2-il) carbonil)amino)-1,3-tiazol-5-carboxílico y sus sales, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciónes.
DOP2011000203A (es) Derivados de pirimidin indol para el tratamiento de cancer
NI201000003A (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas.
DOP2010000387A (es) Compuestos pirazolicos 436
UY32694A (es) Derivados heterocíclicos de urea y métodos de uso de los mismos
UY32316A (es) Derivados de piperidina utiles en el tratamiento de infecciones bacterianas
CO6382113A2 (es) Compuestos quimicos
UY31805A (es) Agonistas m1, composiciones farmacéuticas de los mismos, procesos para su preparacion y sus usos para el tratamiento del dolor
CU20100237A7 (es) Derivados heterocíclicos de la urea y sus métodos de empleo
CU20100172A7 (es) Derivados heterocíclicos de urea y métodos de uso de los mismos-211